These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28737711)

  • 41. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
    Vahlne G; Becker S; Brodin P; Johansson MH
    Scand J Immunol; 2008 Jan; 67(1):1-11. PubMed ID: 18028287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.
    Penack O; Gentilini C; Fischer L; Asemissen AM; Scheibenbogen C; Thiel E; Uharek L
    Leukemia; 2005 May; 19(5):835-40. PubMed ID: 15744340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines.
    Konjevic G; Vuletic A; Mirjacic Martinovic K; Krivokuca A; Jankovic R; Babovic N
    J Membr Biol; 2017 Oct; 250(5):507-516. PubMed ID: 28887642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natural Killer Cell Functional Activity After 4-1BB Costimulation.
    Navabi Ss; Doroudchi M; Tashnizi AH; Habibagahi M
    Inflammation; 2015; 38(3):1181-90. PubMed ID: 25520217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells.
    Deauvieau F; Ollion V; Doffin AC; Achard C; Fonteneau JF; Verronese E; Durand I; Ghittoni R; Marvel J; Dezutter-Dambuyant C; Walzer T; Vie H; Perrot I; Goutagny N; Caux C; Valladeau-Guilemond J
    Int J Cancer; 2015 Mar; 136(5):1085-94. PubMed ID: 25046660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
    Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
    Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Silk peptide treatment potentiates natural killer cell activity
    Jang SH; Oh MS; Baek HI; Ha KC; Lee JY; Jang YS
    Pharm Biol; 2019 Dec; 57(1):369-379. PubMed ID: 31156004
    [No Abstract]   [Full Text] [Related]  

  • 48. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells.
    Zhang X; Wei H; Wang H; Tian Z
    Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of influenza A infection on umbilical cord blood natural killer function regulation with interleukin-15.
    Lin SJ; Cheng PJ; Lin TY; Lee PT; Hsiao HS; Kuo ML
    J Infect Dis; 2012 Mar; 205(5):745-56. PubMed ID: 22262794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The detection of NK cell alloreactivity by flow cytometric CD107a assay.
    De Santis D; Foley B; Witt CS; Christiansen FT
    Methods Mol Biol; 2012; 882():477-89. PubMed ID: 22665251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity.
    Mandi Y; Farkas G; Koltai M; Beladi I; Mencia-Huerta JM; Braquet P
    Immunology; 1989 Jul; 67(3):370-4. PubMed ID: 2759659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A New Ex Vivo Method for Effective Expansion and Activation of Human Natural Killer Cells for Anti-Tumor Immunotherapy.
    Yang H; Tang R; Li J; Liu Y; Ye L; Shao D; Jin M; Huang Q; Shi J
    Cell Biochem Biophys; 2015 Dec; 73(3):723-9. PubMed ID: 27259316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
    Mimura K; Kamiya T; Shiraishi K; Kua LF; Shabbir A; So J; Yong WP; Suzuki Y; Yoshimoto Y; Nakano T; Fujii H; Campana D; Kono K
    Int J Cancer; 2014 Sep; 135(6):1390-8. PubMed ID: 24615495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
    Schmidt RE; Caulfield JP; Michon J; Hein A; Kamada MM; MacDermott RP; Stevens RL; Ritz J
    J Immunol; 1988 Feb; 140(3):991-1002. PubMed ID: 3276787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell.
    Bae DS; Hwang YK; Lee JK
    Cell Immunol; 2012; 276(1-2):122-7. PubMed ID: 22613008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells.
    Guo Y; Feng X; Jiang Y; Shi X; Xing X; Liu X; Li N; Fadeel B; Zheng C
    Oncotarget; 2016 Jul; 7(30):48360-48374. PubMed ID: 27356741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation.
    Vacca P; Martini S; Garelli V; Passalacqua G; Moretta L; Mingari MC
    Eur J Immunol; 2013 Feb; 43(2):550-61. PubMed ID: 23192659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demethylating treatment suppresses natural killer cell cytolytic activity.
    Gao XN; Lin J; Wang LL; Yu L
    Mol Immunol; 2009 Jun; 46(10):2064-70. PubMed ID: 19394699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protocol for the clonal analysis of NK cell effector functions by multi-parameter flow cytometry.
    Schönberg K; Hejazi M; Uhrberg M
    Methods Mol Biol; 2012; 903():381-92. PubMed ID: 22782833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.